[HTML][HTML] Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients over 6 months
…, HJ Manley, GN Aweh, V Ladik… - Clinical Journal of the …, 2022 - journals.lww.com
Results Among 1870 patients receiving maintenance dialysis, 1569 had no prior COVID-19.
Patients without prior COVID-19 had declining titers over time. Among 443 recipients of …
Patients without prior COVID-19 had declining titers over time. Among 443 recipients of …
Oral intradialytic nutritional supplement use and mortality in hemodialysis patients
Background Hemodialysis patients have high mortality rates, potentially reflecting underlying
comorbid conditions and ongoing catabolism. Intradialytic oral nutritional supplements may …
comorbid conditions and ongoing catabolism. Intradialytic oral nutritional supplements may …
COVID-19 among US dialysis patients: risk factors and outcomes from a national dialysis provider
…, DC Miskulin, HJ Manley, C Stewart, V Ladik… - American Journal of …, 2021 - Elsevier
Rationale & Objective During the coronavirus disease 2019 (COVID-19) pandemic, patients
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …
receiving maintenance dialysis are a highly vulnerable population due to their comorbidities …
Seroresponse to SARS-CoV-2 vaccines among maintenance dialysis patients
As of October 2021, 3 SARS-CoV-2 vaccines are available in the United States, and all
appear highly effective in the general population. Studies suggest high seroresponse to …
appear highly effective in the general population. Studies suggest high seroresponse to …
Computerized decision support for EPO dosing in hemodialysis patients
DC Miskulin, DE Weiner, H Tighiouart, V Ladik… - American journal of …, 2009 - Elsevier
BACKGROUND: Anemia management in hemodialysis patients poses significant challenges.
The present study explored the hypothesis that computerized dosing of intravenous …
The present study explored the hypothesis that computerized dosing of intravenous …
Developing decision support for dialysis treatment of chronic kidney failure
SR Raghavan, V Ladik… - IEEE Transactions on …, 2005 - ieeexplore.ieee.org
The complexity, variability, quantitative nature, and data density of treatment for chronic kidney
failure make dialysis information systems excellent candidates for computerized decision …
failure make dialysis information systems excellent candidates for computerized decision …
[HTML][HTML] Serial SARS-CoV-2 antibody titers in vaccinated dialysis patients: prevalence of unrecognized infection and duration of seroresponse
…, NC Li, D Miskulin, A Harford, R Sanders, V Ladik… - Kidney Medicine, 2023 - Elsevier
Rationale & Objective Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infections are likely underdiagnosed, but the degree of underdiagnosis among patients receiving …
infections are likely underdiagnosed, but the degree of underdiagnosis among patients receiving …
A real world comparison of HepB (Engerix-B®) and HepB-CpG (Heplisav-B®) vaccine seroprotection in patients receiving maintenance dialysis
HJ Manley, G Aweh, J Frament, V Ladik… - Nephrology Dialysis …, 2023 - academic.oup.com
Background Vaccination against hepatitis B virus (HBV) is recommended for dialysis
patients. Two reports comparing seroprotection (SP) rates following HepB and HepB-CpG in …
patients. Two reports comparing seroprotection (SP) rates following HepB and HepB-CpG in …
Reducing versus discontinuing erythropoietin at high hemoglobin levels
…, DC Miskulin, K Seefeld, V Ladik… - Journal of the …, 2007 - journals.lww.com
A 2006 change in Medicare policy allowed reimbursement for erythropoietin (EPO) in dialysis
patients whose most recent hemoglobin exceeded 13 g/dl. We investigated the effects of a …
patients whose most recent hemoglobin exceeded 13 g/dl. We investigated the effects of a …
SARS-CoV-2 Infection and Outcomes in Chronic Dialysis Patients: PO0711
EK Lacson, GN Aweh, V Ladik, HJ Manley… - Journal of the …, 2020 - journals.lww.com
Background: The SARS-COV-2 pandemic (COVID) impacted ESRD patients on dialysis,
categorized by the CDC as immunocompromised. We describe the characteristics and …
categorized by the CDC as immunocompromised. We describe the characteristics and …
